Gene · 900
CCNG1: cyclin G1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CCNG1: cyclin G1. Genes, record 900. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/900
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P51959 | Cyclin-G1 | 295 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents56
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 6908 | P51959 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 6908 | P51959 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 5757 | P51959 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 5758 | P51959 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 21082 | P51959 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 21083 | P51959 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 124053 | P51959 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 124054 | P51959 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 1756 | P51959 | Espacenet |
| US 10501513 B2 | 2019-12-10 | 5757 | P51959 | Espacenet |
1 to 10 of 56
See all 56 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,201
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CCNG1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 11 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 10 | 2025 |
| R01HL128239 | Genetic and molecular basis for SRSF2 mutations in myelodysplasia | 4 | 2025 |
| P30CA046592 | University of Michigan Rogel Cancer Center Support Grant 2023-2028 | 3 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 3 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 3 | 2025 |
| P20GM103446 | Delaware INBRE | 2 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 2 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 1,201Source NIH's project files
See all 1,201 nih grantsPapers2,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MicroRNA-122 as a regulator and biomarker of liver disease. | J Mol Med (Berl) | 2026 | 42760391 | PubTator, text mining | PubMed |
| Statement of Retraction: The stimulative function of long noncoding RNA CDKN2B-AS1 in osteosarcoma by targeting the microRNA-122/CCNG1 axis. | J Recept Signal Transduct Res | 2026 | 42639709 | PubTator, text mining | PubMed |
| Association of self-reported sports volume and discipline with atrial arrhythmia prevalence in middle-aged males. | Eur Heart J Open | 2026 | 42368428 | PubTator, text mining | PubMed |
| Salivary Gene Expression Changes after Total Body Irradiation in Leukemia Patients: Toward Non-invasive Biodosimetry. | Radiat Res | 2026 | 42235939 | PubTator, text mining | PubMed |
| Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association study. | Lancet Neurol | 2026 | 42127933 | PubTator, text mining | PubMed |
| Protein arginine methyltransferases in cancer: mechanisms, functions, and therapeutic opportunities. | J Biomed Sci | 2026 | 41928257 | PubTator, text mining | PubMed |
| [Retracted] MicroRNA-27a functions as an oncogene in human osteosarcoma by targeting CCNG1. | Oncol Lett | 2026 | 41918806 | PubTator, text mining | PubMed |
| Eccentric Cycling Improves Motor Learning More Than Concentric Cycling. | Scand J Med Sci Sports | 2026 | 41902446 | PubTator, text mining | PubMed |
| Analysis of Clinical Benefit Using DNG64-CAR-V Chimeric Tumor Targeted Amphotropic RNA Vector in CCNG1 Expressing Cancers. | Anticancer Res | 2026 | 41895777 | PubTator, text mining | PubMed |
| Single-cell insights into trophoblast heterogeneity and adaptive dysfunction in selective fetal growth restriction. | Commun Biol | 2026 | 41845016 | PubTator, text mining | PubMed |
1 to 10 of 2,141
See all 2,141 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/900
GET https://conductscience.org/api/genes/v1/900/patents?page=2